Cargando…
Purinergic receptor P2Y12 boosts autoimmune hepatitis through hexokinase 2-dependent glycolysis in T cells
Increasing evidence suggests that immunometabolism has started to unveil the role of metabolism in shaping immune function and autoimmune diseases. In this study, our data show that purinergic receptor P2Y12 (P2RY12) is highly expressed in concanavalin A (ConA)-induced immune hepatitis mouse model a...
Autores principales: | Zhuang, Wei, Liu, Xiucheng, Liu, Guangyu, Lv, Jie, Qin, Hao, Wang, Chun, Xie, Ling, Saimaier, Kaidireya, Han, Sanxing, Shi, Changjie, Hua, Qiuhong, Zhang, Ru, Du, Changsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367548/ https://www.ncbi.nlm.nih.gov/pubmed/37497007 http://dx.doi.org/10.7150/ijbs.85133 |
Ejemplares similares
-
CXCR1 drives the pathogenesis of EAE and ARDS via boosting dendritic cells-dependent inflammation
por: Zhuang, Wei, et al.
Publicado: (2023) -
Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis
por: Yuan, Jian, et al.
Publicado: (2020) -
MicroRNA-202 suppresses glycolysis of pancreatic cancer by targeting hexokinase 2
por: Wang, Shuang-Jia, et al.
Publicado: (2021) -
Histone H2AX promotes metastatic progression by preserving glycolysis via hexokinase-2
por: Liu, Yue, et al.
Publicado: (2022) -
STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells
por: Li, Man, et al.
Publicado: (2017)